内镜下经蝶入路治疗更具侵袭性的儿童垂体腺瘤的结局:单中心经验的早期与晚期结果
该研究回顾性分析了1997年8月至2022年6月单中心3256例内镜下经蝶手术中70例(2.1%)儿童垂体腺瘤患者的早期与晚期结局,并描述与侵袭性生长相关的组织病理学特征。激素分泌型腺瘤的早期/晚期缓解率因类型而异,非功能型肿瘤全切率达93.3%。作者认为儿童人群特点及疾病侵袭性带来治疗挑战,除手术外需针对肿瘤形态和生物学特征的辅助治疗。
要点
- 儿童垂体腺瘤占儿童幕上肿瘤约3%,内镜下经蝶手术报道较少。
- 非功能型肿瘤全切率93.3%;激素分泌型腺瘤早期/晚期缓解率因类型不同。
- 稀疏颗粒型促肾上腺皮质激素瘤、稀疏颗粒型生长激素瘤和密集颗粒型泌乳素瘤被归类为侵袭性组织病理学亚型。
核心结论
- 儿童人群的独特特征及疾病的侵袭性带来相当大的治疗挑战。
- 为提高治疗成功率,除手术治疗外,需要适合肿瘤形态和生物学特征的现有辅助治疗。
研究设计与样本
- 回顾性研究,纳入1997年8月至2022年6月在Kocaeli大学医学院神经外科和垂体研究中心接受内镜下经蝶手术的垂体腺瘤患者共3256例。
- 其中70例(2.1%)儿童患者(年龄≤18岁;25例男性,45例女性)经病理诊断为垂体腺瘤,进行回顾性分析。
主要发现
- 患者平均年龄15.5±2.3岁。
- 激素分泌型腺瘤中,促肾上腺皮质激素分泌型19例(34.5%),生长激素分泌型13例(23.6%),泌乳素分泌型19例(34.5%),生长激素-泌乳素混合分泌型4例(7.2%)。
- 非功能型肿瘤全切率为93.3%。
- 肢端肥大症早期/晚期手术缓解率分别为61.5%/46.1%(平均随访63.7±49.3个月);库欣病为78.9%/68.4%(47.8±51.0个月);泌乳素瘤为57.8%/31.5%(72.2±59.5个月);生长激素-泌乳素混合分泌腺瘤为25%/25%(35.2±31.4个月)。
- 5例稀疏颗粒型促肾上腺皮质激素瘤、5例稀疏颗粒型生长激素瘤和11例密集颗粒型泌乳素瘤被归类为侵袭性组织病理学亚型。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pediatric pituitary adenomas are rare lesions and account for approximately 3% of all supratentorial tumors in children. There is a paucity of reports on endoscopic transsphenoidal surgery in children. The aim of this study was to assess the early/late outcomes of endoscopic pediatric pituitary adenoma surgery at a high-volume tertiary center, as well as to characterize the factors associated with aggressive growth, including the histopathological features. METHODS: Between August 1997 and June 2022, a total of 3256 patients underwent endoscopic transsphenoidal surgery for pituitary adenoma at the Department of Neurosurgery and Pituitary Research Center of the Kocaeli University School of Medicine. Of these, 70 (2.1%) pediatric patients (25 males, 45 females) (age ≤18 years) with a pathological diagnosis of pituitary adenoma were retrospectively reviewed. RESULTS: The mean age of patients was 15.5 ± 2.3 years. Among the hormone-secreting adenomas, 19 (34.5%) were adrenocorticotrophic hormone secreting, 13 (23.6%) were growth hormone secreting, 19 (34.5%) were prolactin secreting, and 4 (7.2%) were both growth hormone-prolactin secreting. Gross total resection was achieved in 93.3% of nonfunctional tumors. The early/late surgical remission rates for hormone-secreting adenomas were 61.5%/46.1% (mean follow-up: 63.7 ± 49.3 months) for acromegaly, 78.9%/68.4% (47.8 ± 51.0 months) for Cushing disease, 57.8%/31.5% (72.2 ± 59.5 months) for prolactinoma, and 25%/25% (35.2 ± 31.4 months) for growth hormone-prolactin-secreting adenomas. Five sparsely granulated corticotroph tumors, 5 sparsely granulated somatotroph tumors, and 11 densely granulated lactotroph tumors were classified as aggressive histopathological subtypes. CONCLUSIONS: The unique characteristics of the pediatric population and the aggressiveness of the disease in this population pose considerable therapeutic challenges. To increase treatment success, current adjuvant therapies that are appropriate for the morphological and biological characteristics of the tumor are required in addition to surgical treatment.
引用
- Caklili M, Yilmaz E, Duman Ozturk S, et al. Outcomes of Endoscopic Transsphenoidal Approach for More Aggressive Pediatric Pituitary Adenomas: Early- and Late-Term Results from a Single Center Experience. World Neurosurg. 2023. PMID: 37271260. doi:10.1016/j.wneu.2023.05.111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。